Exosomes derived from MSC as drug system in osteoarthritis therapy

Exosomes derived from MSC as drug system in osteoarthritis therapy

Osteoarthritis (OA) is the most common degenerative disease of the joint with irreversible cartilage damage as the main pathological feature. With the development of regenerative medicine, mesenchymal stem cells (MSCs) have been found to have strong therapeutic potential. However, intraarticular MSC...

Full description

Bibliographic Details
Main Authors: Shuzhan Wen, Xin Huang, Jingchun Ma, Guanglei Zhao, Tiancong Ma, Kangming Chen, Gangyong Huang, Jie Chen, Jingsheng Shi, Siqun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
exosome
mesenchymal stem cell
osteoarthritis
drug delivery
engineered exosome
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2024.1331218/full

Internet

https://www.frontiersin.org/articles/10.3389/fbioe.2024.1331218/full

Similar Items